Immunitas Therapeutics Funding: $97M Raised, Series B (2021)
Immunitas Therapeutics is based in Waltham, Massachusetts. It has raised $97M in total funding. Latest round: Series B.
Immunitas Therapeutics funding overview
Immunitas Therapeutics is based in Waltham, Massachusetts. Immunitas Therapeutics has raised $97M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Immunitas Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Agent Capital, Evotec, Leaps by Bayer, Novartis Venture Fund. 4 distinct backers are named across the disclosed rounds.
Immunitas Therapeutics at a glance
Total raised
$97M
Latest round
Series B
Latest round date
January 2021
Headquarters
Waltham, Massachusetts
Notable investors
Agent Capital, Evotec, Leaps by Bayer, Novartis Venture Fund
Frequently asked about Immunitas Therapeutics funding
How much has Immunitas Therapeutics raised?
Immunitas Therapeutics has raised $97M in total disclosed funding across the rounds on record.
Who has invested in Immunitas Therapeutics?
Agent Capital, Evotec, Leaps by Bayer, Novartis Venture Fund are named among the investors backing Immunitas Therapeutics.
What was the latest Immunitas Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is Immunitas Therapeutics based?
Immunitas Therapeutics is based in Waltham, Massachusetts.
When did Immunitas Therapeutics last raise?
The last disclosed Immunitas Therapeutics round closed in January 2021 at Series B.
Every Immunitas Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Waltham at a similar stage.
